Mark Hayes
Keine laufenden Positionen mehr
Profil
Mark Hayes worked as a Vice President of Regulatory Affairs at Synageva BioPharma Corp.
Prior to that, he obtained an undergraduate degree from Davidson College and a doctorate degree from the University of Florida.
Ehemalige bekannte Positionen von Mark Hayes
| Unternehmen | Position | Ende |
|---|---|---|
| SYNAGEVA BIOPHARMA CORP | General Counsel | - |
Ausbildung von Mark Hayes
| Davidson College | Undergraduate Degree |
| University of Florida | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
